182 related articles for article (PubMed ID: 8902982)
1. Transport processes in fibrinolysis and fibrinolytic therapy.
Blinc A; Francis CW
Thromb Haemost; 1996 Oct; 76(4):481-91. PubMed ID: 8902982
[TBL] [Abstract][Full Text] [Related]
2. The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases.
Zidansek A; Blinc A
Thromb Haemost; 1991 May; 65(5):553-9. PubMed ID: 1831302
[TBL] [Abstract][Full Text] [Related]
3. Flow through clots determines the rate and pattern of fibrinolysis.
Blinc A; Kennedy SD; Bryant RG; Marder VJ; Francis CW
Thromb Haemost; 1994 Feb; 71(2):230-5. PubMed ID: 8191404
[TBL] [Abstract][Full Text] [Related]
4. Dependence of blood clot lysis on the mode of transport of urokinase into the clot--a magnetic resonance imaging study in vitro.
Blinc A; Planinsic G; Keber D; Jarh O; Lahajnar G; Zidansĕk A; Demsar F
Thromb Haemost; 1991 May; 65(5):549-52. PubMed ID: 1871717
[TBL] [Abstract][Full Text] [Related]
5. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
6. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
Poredos P; Videcnik V
Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
[TBL] [Abstract][Full Text] [Related]
7. The effect of flow on lysis of plasma clots in a plasma environment.
Sakharov DV; Rijken DC
Thromb Haemost; 2000 Mar; 83(3):469-74. PubMed ID: 10744155
[TBL] [Abstract][Full Text] [Related]
8. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
Wootton DM; Popel AS; Alevriadou BR
Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
[TBL] [Abstract][Full Text] [Related]
9. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and biophysical conditions for blood clot lysis.
Sabovic M; Blinc A
Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
[TBL] [Abstract][Full Text] [Related]
11. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
[TBL] [Abstract][Full Text] [Related]
12. The effect of 40 kHz ultrasound on tissue plasminogen activator-induced clot lysis in three in vitro models.
Pieters M; Hekkenberg RT; Barrett-Bergshoeff M; Rijken DC
Ultrasound Med Biol; 2004 Nov; 30(11):1545-52. PubMed ID: 15588966
[TBL] [Abstract][Full Text] [Related]
13. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
Wu JH; Siddiqui K; Diamond SL
Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion.
Anand S; Kudallur V; Pitman EB; Diamond SL
Ann Biomed Eng; 1997; 25(6):964-74. PubMed ID: 9395042
[TBL] [Abstract][Full Text] [Related]
15. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
Hantgan RR; Jerome WG; Handt S
Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
[TBL] [Abstract][Full Text] [Related]
16. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis and the risk of venous and arterial thrombosis.
Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
19. Engineering design of optimal strategies for blood clot dissolution.
Diamond SL
Annu Rev Biomed Eng; 1999; 1():427-62. PubMed ID: 11701496
[TBL] [Abstract][Full Text] [Related]
20. In vitro simulation of extremely activated thrombolysis.
Stief TW
Clin Appl Thromb Hemost; 2008 Apr; 14(2):238-40. PubMed ID: 18160585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
